CMS announces new repayment terms for Accelerated and Advance Payment programs

Oct 09, 2020 - 01:45 PM
CMS logo

The Centers for Medicare & Medicaid Services yesterday announced new repayment terms for payments received under its Accelerated and Advance Payment programs, including a longer time period before repayment, lower recoupment rates during repayment, lower interest on remaining unpaid balance, and additional repayment flexibilities.

The announcement implements provisions of the Continuing Appropriations Act, 2021 and Other Extensions Act, which was enacted on Oct. 1, 2020.

The repayment terms are amended for all providers and suppliers who requested and received AAPs during the COVID-19 public health emergency. In addition to describing the new terms, CMS announced that the agency no longer will accept applications for AAPs as they relate to COVID-19. CMS also clarified that Provider Relief Funds can be used toward repayment of these Medicare loans.

Related News Articles

Headline
FDA to limit COVID-19 vaccine to people over 65, others at high risk for serious illness
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England…
Headline
Judge: HHS has authority to preapprove implementation of 340B ‘rebate models’
A U.S. district court judge for the District of Columbia May 15 ruled the Department of Health and Human Services must preapprove the use of 340B “rebate…
Headline
CMS releases draft guidance for third cycle of Medicare drug price negotiations
The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation…
Headline
AHA files brief defending South Dakota’s 340B contract pharmacy law
The AHA May 14 filed an amicus brief in the U.S. District Court for the District of South Dakota in defense of the state’s 340B contract pharmacy law…
Headline
AHA comments to HHS on 340B drug rebate models
The AHA May 9 urged the Department of Health and Human Services to deny drug companies’ requests to approve their unlawful 340B rebate models. “The 340B…
Headline
House Ways and Means Committee advances its portion of FY 2025 reconciliation bill 
The House Ways and Means Committee today advanced its portion of the fiscal year 2025 reconciliation bill by a 26-19 vote along party lines, following an hours…